Related Experiment Videos
Influenza A(H1N1): a widening spectrum?
P W Gill1, A M Murphy, A L Cunningham
1Department of Virology, Institute of Clinical Pathology and Medical Research, Westmead Hospital, NSW.
The Medical Journal of Australia
|September 16, 1991
Summary
The H1N1 influenza virus, which reappeared in 1977, initially affected younger populations. Continued antigenic drift led to the virus attacking a wider age range by 1988.
Area of Science:
- Virology
- Epidemiology
- Immunology
Background:
- The H1N1 influenza subtype resurged globally in 1977 after being displaced by other strains.
- The reappeared H1N1 strain, A/USSR/90/77, primarily infected individuals born after the 1950s, causing minimal mortality.
- This strain did not displace the co-circulating H3N2 influenza virus.
Purpose of the Study:
- To investigate the incidence of H1N1 influenza from 1977 to 1988 in unvaccinated individuals.
- To assess the impact of ongoing antigenic drift on the H1N1 virus's characteristics and spread.
- To determine if viral evolution would broaden the age groups affected by H1N1.
Main Methods:
- A prospective study involving general practitioners and virological confirmation.
- Inclusion of unvaccinated volunteers, with high-risk participants encouraged to be vaccinated and withdraw.
- Monitoring of participants over the study period, with varying numbers at different stages (287 in 1977-1981, 207 by 1988).
Main Results:
- The initial H1N1 strains (A/USSR/90/77, A/Brazil/11/78) predominantly infected younger individuals with limited prior H1N1 exposure.
- By the 1988 epidemic, the H1N1 strain A/Taiwan/1/86 demonstrated an expanded age range of attack compared to earlier strains.
- Negligible mortality was observed during the early H1N1 pandemics, largely due to the low risk of severe outcomes in the younger demographic.
Conclusions:
- Continued antigenic drift in H1N1 influenza viruses is likely to result in a progressively wider spectrum of age groups being affected.
- The findings suggest a dynamic evolution of H1N1, necessitating ongoing surveillance and potential vaccine updates.